000 01562 a2200397 4500
005 20250518023559.0
264 0 _c20191015
008 201910s 0 0 eng d
022 _a1011-601X
040 _aNLM
_beng
_cNLM
100 1 _aAbbasi, Muhammad Athar
245 0 0 _aSynthesis of some new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamides as possible therapeutic agents for Alzheimer's disease and Type-2 Diabetes.
_h[electronic resource]
260 _bPakistan journal of pharmaceutical sciences
_cJan 2019
300 _a61-68 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetylcholinesterase
_xmetabolism
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aButyrylcholinesterase
_xmetabolism
650 0 4 _aCholinesterase Inhibitors
_xchemical synthesis
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aGlycoside Hydrolase Inhibitors
_xchemical synthesis
650 0 4 _aMass Spectrometry
650 0 4 _aMolecular Structure
650 0 4 _aProton Magnetic Resonance Spectroscopy
650 0 4 _aStructure-Activity Relationship
650 0 4 _aSulfonamides
_xchemical synthesis
650 0 4 _aalpha-Glucosidases
_xmetabolism
700 1 _aRehman, Azizur
700 1 _aSiddiqui, Sabahat Zahra
700 1 _aHadi, Noorul
700 1 _aMumtaz, Ayesha
700 1 _aShah, Syed Adnan Ali
700 1 _aAshraf, Muhammad
700 1 _aAbbasi, Ghulam Hasan
773 0 _tPakistan journal of pharmaceutical sciences
_gvol. 32
_gno. 1
_gp. 61-68
999 _c29381127
_d29381127